|
MORF
|
Morphic Holding, Inc.
|
0.30%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
0.30%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.29%
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.29%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.28%
|
US
|
NASDAQ
|
|
MLAB
|
Mesa Laboratories, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.27%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
VRAY
|
ViewRay, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
KIDS
|
OrthoPediatrics Corp.
|
0.25%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
CYRX
|
CryoPort, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.24%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
NVAX
|
Novavax, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.23%
|
US
|
NASDAQ
|